NFI transcriptionally represses CDON and is required for SH-SY5Y cell survival
Betül Uluca1, Cemre Lektemur Esen2, Sinem Saritas Erdogan2
1Department of Molecular Biology and Genetics, Istanbul Technical University, Maslak, Istanbul 34469, Turkey; Department of Molecular Biotechnology, Turkish-German University, Beykoz, Istanbul 34820, Turkey.
Abstract:
Nuclear Factor One (NFI) family of transcription factors regulate proliferation and multiple aspects of differentiation, playing analogous roles in embryonic development and various types of cancer. While all NFI family members are expressed in the developing brain and are involved in progression of brain cancers, their role in neuroblastoma has not been studied. Here we show that NFIB is required for the survival and proliferation of SH-SY5Y neuroblastoma cells, assessed by viability and colony formation assays. Cdon, an Ig superfamily member, is a SHH dependence receptor that acts as a tumor suppressor in neuroblastoma. In the absence of NFI, Cdon is upregulated in the developing mouse brain, however the mechanisms by which its transcription is regulated remains unknown. We report CDON as a downstream target of NFIs in SH-SY5Y cells. There are three putative NFI binding sites within the one kb CDON promoter, two of which are occupied by NFIs in SH-SY5Y cells and human neural stem cells. In dual-luciferase assays, Nfib directly represses CDON proximal promoter activity. Moreover, silencing NFIB leads to upregulation of CDON in SH-SY5Y cells, however, decreased cell proliferation in NFIB silenced cells could not be rescued by concomitantly silencing CDON, suggesting other molecular players are involved. For instance, p21, an NFI target in glioblastoma and breast cancer cells, is also upregulated upon NFIB knock-down. We propose that NFIB is indispensable for SH-SY5Y cells which may involve regulation of apoptosis inducer proteins CDON and p21.
Insights
Nuclear Factor One (NFIB) is essential for neuroblastoma cell survival and proliferation. NFIB directly represses CDON promoter activity, and its absence upregulates CDON and p21, suggesting roles in apoptosis regulation.
Area of Science:
- Molecular Biology
- Cancer Research
- Neuroscience
Background:
- Nuclear Factor One (NFI) transcription factors regulate cell proliferation and differentiation in development and cancer.
- While NFI family members are involved in brain development and cancer, their specific role in neuroblastoma remains uncharacterized.
Purpose of the Study:
- To investigate the role of NFIB in neuroblastoma cell survival and proliferation.
- To identify downstream targets of NFIB in neuroblastoma and elucidate regulatory mechanisms.
Main Methods:
- Cell viability and colony formation assays were used to assess NFIB's role in SH-SY5Y neuroblastoma cells.
- Dual-luciferase assays and gene silencing (NFIB, CDON) were employed to study gene regulation.
- Western blotting and qPCR were used to analyze protein and gene expression levels of CDON and p21.
Main Results:
- NFIB is required for the survival and proliferation of SH-SY5Y neuroblastoma cells.
- CDON was identified as a direct downstream target of NFIB, with NFIB repressing CDON promoter activity.
- NFIB silencing led to CDON and p21 upregulation, but CDON silencing did not rescue proliferation defects, indicating other factors are involved.
Conclusions:
- NFIB plays a critical role in neuroblastoma cell survival and proliferation.
- NFIB directly regulates CDON expression, and its knockdown results in the upregulation of apoptosis-related genes CDON and p21.
- Further investigation is needed to fully elucidate the molecular mechanisms by which NFIB influences neuroblastoma progression.
Related Concept Videos
Co-activators and Co-repressors
Inhibition of Cdk Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Negative Regulator Molecules
Types of RNA
RNA Performs Diverse...
Replicative Cell Senescence


